Publications
- Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia2013 | Faculty of Medicine in Hradec Králové
- Cardiac troponin I seems to be superior to cardiac troponin T in the early detection of cardiac injury associated with anthracycline treatment +12008 | Faculty of Medicine in Hradec Králové
- Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity +12008 | Faculty of Medicine in Hradec Králové
- Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia +12008 | Faculty of Medicine in Hradec Králové
- Continuous 24-hours monitoring of electrocardiogram during anthracycline-based therapy2008 | Faculty of Medicine in Hradec Králové
- Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines +12008 | Faculty of Medicine in Hradec Králové
- The use of biochemical markers in assessment of acute and chronic cardiotoxicity of anthracyclines in hematooncology patients2007 | Faculty of Medicine in Hradec Králové
- Assessment of anthracycline-induced cardiotoxicity with biochemical markers +12007 | Faculty of Medicine in Hradec Králové
- Assessment of acute and chronic cardiac toxicity of anthracyclines with electrocardiography +12007 | Faculty of Medicine in Hradec Králové
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
Loading network view...